India Respiratory Care Devices Market, By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables & Accessories), By Indication (Chronic Obstructive Pulmonary Disease, Infectious Diseases, Asthma, Sleep Apnea, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition, Opportunities and Forecast, 2020-2030F

Market Overview

India Respiratory Care Devices Market was valued at USD 1.50 billion in 2024 and is anticipated to reach USD 2.27 Billion by 2030, with a CAGR of 7.07% during 2025-2030. Respiratory care devices are a category of medical equipment designed to assist individuals with respiratory conditions in breathing more effectively, improve their lung function, and manage various respiratory disorders.

These devices are used in healthcare facilities, home healthcare settings, and sometimes by individuals themselves. They serve a range of diagnostic, therapeutic, and supportive functions to address respiratory issues. Ventilators, also known as mechanical ventilators or respirators, are devices that assist patients in breathing when they are unable to do so adequately on their own. They deliver controlled amounts of air or oxygen into the lungs, supporting patients with respiratory failure or severe breathing difficulties.

Nebulizers convert liquid medication into a fine mist that can be inhaled by the patient. They are commonly used to deliver medications for respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Pulse oximeters are non-invasive devices that measure the oxygen saturation level in the blood, as well as the patient's pulse rate. They are commonly used to monitor oxygen levels and heart rate, especially in patients with respiratory conditions. India faces severe air pollution in many urban areas, leading to a higher incidence of respiratory illnesses. This makes respiratory care devices essential for managing and treating these conditions.

Ongoing advancements in respiratory care device technology, such as more efficient ventilators, oxygen concentrators, and portable devices, drive market growth as healthcare providers seek the latest and most effective equipment. Growing awareness about respiratory health and the importance of early diagnosis and treatment has led to an increased demand for diagnostic and monitoring devices. Concerns about the impact of environmental factors, such as pollution and allergens, on respiratory health have driven demand for devices that assess and address these concerns.

Key Market Drivers

Technological Advancements

Technological advancements have transformed respiratory care devices, improving diagnosis, treatment, and patient management across India. Modern systems now emphasize precision, comfort, and data accuracy, driving better outcomes for patients with chronic or acute respiratory conditions. Ventilator technology, for instance, has evolved to include modes such as pressure control, volume control, and adaptive support, allowing clinicians to tailor treatment to each patient’s condition. In February 2024, Getinge introduced its advanced Servo-c ventilator in India to provide high-quality respiratory support for both adult and pediatric patients.

In September 2021, Pune-based med-tech startup Noccarc Robotics developed affordable, high-performance ventilators within 90 days to meet pandemic-driven shortages. By August 2023, the Technology Development Board (TDB) under the Department of Science and Technology (DST) approved ₹3.94 crore in funding to Noccarc, an IIT Kanpur-incubated company, to expand its ventilator manufacturing and R&D capabilities. Portable and energy-efficient ventilators now allow patients to receive respiratory support outside hospital settings, while oxygen concentrators have become lighter, more efficient, and battery-operated for home and travel use. Liquid oxygen systems provide uninterrupted oxygen supply without frequent cylinder replacement, enhancing convenience for long-term users.

Digital innovation is reshaping patient monitoring and adherence. Lupin introduced “ADHERO,” a Bluetooth-enabled device for metered-dose inhalers that tracks usage and improves adherence for asthma and COPD patients. Glenmark launched India’s first digital dose inhaler with a real-time dose counter and low-dose alert to help users manage medication effectively. Cipla advanced digital health integration with “CipAir,” an AI-based mobile app launched in December 2024 for asthma screening through acoustic analysis. Similarly, Oxymed launched the SleepEasy Auto CPAP device in August 2024, integrating the FlowSens algorithm for greater comfort at lower cost.

Remote monitoring has become integral to respiratory care. Devices now transmit vital data directly to healthcare professionals for timely intervention. CPAP systems have become quieter and more portable with integrated humidifiers to improve sleep therapy comfort. Air purifiers and filtration devices incorporate HEPA and activated carbon filters to remove allergens, pollutants, and pathogens, supporting patients with chronic respiratory conditions.

Emerging technologies are shaping the next phase of respiratory care. AI is being used to predict symptom exacerbations, personalize treatment plans, and analyze large health datasets. Researchers are also developing breath sensors to detect biomarkers linked to infections and lung diseases. Nanotechnology enables precise drug delivery to affected lung areas, minimizing side effects. Meanwhile, 3D printing is being explored for custom respiratory devices, such as airway splints for pediatric patients with tracheobronchomalacia. These innovations collectively strengthen India’s respiratory care ecosystem, ensuring accessibility, affordability, and better patient outcomes across care settings.

Increasing Aging Population

As people age, their vulnerability to respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea increases. Natural aging weakens lung function, reduces elasticity, and limits respiratory capacity, making older individuals more susceptible to these conditions. India’s elderly population is expanding rapidly, projected to reach about 230 million by 2036, representing nearly 15% of the total population, and 319 million by 2050. The Longitudinal Ageing Study of India (LASI) 2021 reported that seniors account for 12% of the population, growing at roughly 3% annually. The decadal growth rate of India’s elderly population stands at 41%, with the share of elderly expected to double to 20.8% by 2050. By 2046, the elderly population will likely surpass the number of children aged 0–15 years. This demographic shift has significant healthcare implications, especially for respiratory care.

Chronic diseases such as hypertension, diabetes, and heart disorders often coexist with respiratory problems, worsening overall health outcomes. The decline in lung capacity and respiratory muscle strength that accompanies aging makes it difficult for seniors to maintain adequate oxygen levels. Respiratory care devices such as oxygen concentrators, nebulizers, and ventilators help manage symptoms, improve oxygenation, and enhance quality of life for older adults.

Older individuals are also at higher risk of respiratory infections like pneumonia and influenza, which can lead to severe complications. Devices for oxygen therapy and aerosol medication delivery are essential for treating such infections. Sleep-related breathing disorders, particularly sleep apnea, are increasingly prevalent among seniors. Studies show that around 11% of Indian adults experience obstructive sleep apnea (OSA), with about 5% suffering from moderate to severe forms. The overlap of OSA and COPD, known as overlap syndrome, affects about 41.3% of patients, particularly those above 60 years. Continuous Positive Airway Pressure (CPAP) machines remain critical for managing sleep apnea in this age group.

Older adults often require respiratory support after surgery or hospitalization to aid recovery. Long-term care facilities also rely heavily on respiratory care systems to address chronic and acute conditions among residents. Moreover, as more elderly individuals prefer to age at home, the need for portable and easy-to-use home respiratory devices has surged. Innovations such as compact oxygen concentrators and smart monitoring systems have made home respiratory care more accessible and comfortable.

However, affordability remains a challenge. More than 40% of India’s elderly belong to the poorest wealth quintile, with 18.7% having no income and only 18% of those over 60 years covered by health insurance. Despite these barriers, the increasing awareness of respiratory health, technological improvements, and a growing aging population will continue to accelerate the demand for respiratory care devices in India.

Rising Environmental Factors

High air pollution levels across India continue to strain public health, particularly respiratory health. Pollutants such as particulate matter (PM2.5), ozone, and nitrogen dioxide cause and worsen diseases like asthma and chronic obstructive pulmonary disease (COPD). The Air Quality Life Index (AQLI) 2025 report noted that all Indians live in regions where PM2.5 levels exceed the WHO’s safe limit of 5 μg/m³. Around 544.4 million people in the northern plains are exposed to hazardous air. In January 2025, only 22 cities recorded “Good” air quality (0–30 µg/m³), while 113 cities reported “Satisfactory” (31–60 µg/m³) and 71 cities “Moderate” (61–90 µg/m³) levels. Byrnihat was India’s most polluted city in January 2025, with an average PM2.5 concentration of 214 µg/m³, breaching the daily NAAQS limit of 60 µg/m³ for every day of the month. Delhi followed with a monthly average PM2.5 of 165 µg/m³. Such high pollution levels increase the need for respiratory care devices for prevention and treatment.

Environmental allergens like pollen, mold, pet dander, and dust mites often trigger allergic rhinitis and asthma. Devices such as nebulizers and inhalers are widely used to relieve symptoms during high-allergen periods. Climate change and events like wildfires, heat waves, and prolonged dry spells worsen air quality, leading to respiratory distress. Occupational exposure to dust, smoke, and chemicals also contributes to chronic respiratory diseases, highlighting the importance of respiratory care systems in workplaces and industrial areas.

Indoor air pollution further adds to respiratory risks. Poor ventilation, tobacco smoke, and household pollutants can cause breathing issues. Growing awareness has driven adoption of air purifiers and home-based respiratory devices to improve indoor air quality. Regional and climatic factors also play a role. Coastal zones face high humidity and mold, while dry regions deal with dust storms. Southern and eastern cities show urban aerosol pollution islands, while northern and northwestern cities, despite high overall pollution, appear relatively cleaner in localized studies. These regional variations influence demand for respiratory care equipment tailored to local conditions.

Natural disasters like floods, wildfires, and storms worsen air quality by increasing particulate matter. In such cases, respiratory care devices become vital for recovery and emergency management. Rising public awareness of pollution’s health impact has led to the use of masks and portable respiratory aids. Ongoing research and real-time air quality data have reinforced the need for respiratory care technologies, driving strong growth in the India Respiratory Care Devices Market.

Download Free Sample Report

Key Market Challenges

Supply Chain Issues

Many respiratory care devices are manufactured using components and materials sourced from various parts of the world. Global disruptions, such as trade disputes, transportation bottlenecks, or the COVID-19 pandemic, can lead to delays in the procurement of these components, affecting the production of devices. Within India, supply chain challenges may include issues related to logistics, distribution, and warehousing. Efficient transportation and warehousing of devices are critical to ensuring that they reach healthcare facilities in a timely manner.

Ensuring the quality and regulatory compliance of respiratory care devices throughout the supply chain can be challenging. It often involves coordination between manufacturers, distributors, and regulatory bodies to meet safety and quality standards. Maintaining an optimal inventory of respiratory care devices can be complex. Overstocking may lead to financial strain, while understocking can result in device shortages when demand is high. An efficient and reliable distribution network is essential for delivering devices to hospitals, clinics, and other healthcare facilities. Delays or inefficiencies in this network can disrupt the availability of devices where they are needed. Supply chain disruptions can impact the cost of manufacturing and transportation. This, in turn, may affect the pricing of respiratory care devices and their affordability for healthcare providers and patients.

Insurance and Reimbursement

In India, many individuals, particularly in lower-income segments, do not have adequate health insurance coverage. This limits their ability to afford respiratory care devices, which can be expensive. As a result, some patients may not have access to necessary devices. Even when individuals have health insurance, the coverage for respiratory care devices may be incomplete or have restrictions. Insurance plans may not fully cover the cost of devices, leaving patients with out-of-pocket expenses. Different insurance providers may have varying policies on the coverage of respiratory care devices.

This can lead to confusion and inconsistencies in reimbursement, making it challenging for patients to understand what is covered. Some insurance plans may require pre-authorization or extensive documentation before approving reimbursement for respiratory care devices. This can be time-consuming and burdensome for patients and healthcare providers. Many patients and healthcare providers may not be fully aware of the extent of insurance coverage available for respiratory care devices. This lack of awareness can result in missed opportunities for reimbursement. Accurate and detailed documentation is often required to secure reimbursement. Incomplete or incorrect documentation can result in claim denials and delayed reimbursement.

Key Market Trends

Home Healthcare

Home healthcare provides patients with the convenience of receiving respiratory care in the comfort of their homes. Patients no longer need to travel to healthcare facilities for routine check-ups, device monitoring, or treatment. Home healthcare can be a cost-effective alternative to hospital or clinic-based care. It eliminates the need for extended hospital stays and reduces healthcare expenditures for patients and insurers. India has a growing elderly population, and many older adults prefer to age in place. Home healthcare allows elderly individuals with respiratory conditions to receive care while maintaining their independence.

Many respiratory conditions, such as COPD and sleep apnea, require ongoing management and monitoring. Home healthcare offers a seamless way to address the long-term needs of patients. Advances in telemedicine and remote monitoring technology enable healthcare providers to monitor patients' respiratory health in real-time. This technology is increasingly integrated into respiratory care devices, allowing for remote data transmission.

Home-based ventilators and related respiratory care devices make it possible for ventilator-dependent patients to receive care at home. This can improve their quality of life and reduce the burden on healthcare facilities. Home healthcare providers can tailor care plans to the specific needs of patients, providing personalized care and education about respiratory conditions and device use.

Segmental Insights

Product Type Insights

In 2024, the India Respiratory Care Devices Market largest share was held by Diagnostic Devices segment and is predicted to continue expanding over the coming years. Diagnostic devices play a crucial role in the early diagnosis and continuous monitoring of respiratory conditions. Timely identification of respiratory issues is essential for effective treatment. As a result, the demand for diagnostic devices in the Indian healthcare system has been steadily increasing. Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea have a significant prevalence in India.

To manage these conditions, healthcare providers rely on diagnostic devices such as spirometers, peak flow meters, and pulse oximeters to assess lung function and oxygen saturation levels. There has been a growing awareness among the general population and healthcare professionals about the importance of early diagnosis and regular monitoring of respiratory conditions.

This awareness has increased the adoption of diagnostic devices. Various government healthcare initiatives and programs have emphasized the importance of diagnosing respiratory conditions at an early stage. These programs have often included the procurement and distribution of diagnostic devices to healthcare facilities. The presence of specialized clinics and pulmonologists who focus on respiratory health and diseases has driven the demand for diagnostic devices. These healthcare providers rely on accurate diagnostic tools to assess and manage patients with respiratory conditions.

End-User Insights

In 2024, the India Respiratory Care Devices Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years.  Hospitals and clinics in India are equipped with advanced medical infrastructure and facilities. They often have specialized respiratory care units, intensive care units (ICUs), and pulmonary departments. These facilities require a wide range of respiratory care devices to treat patients with various respiratory conditions. Hospitals and clinics serve as central locations for diagnosing and treating patients with respiratory issues.

They are equipped to provide comprehensive care, which includes the use of various respiratory care devices such as ventilators, oxygen concentrators, and nebulizers. Respiratory care devices are essential for patients in critical condition. Hospitals and clinics often treat individuals with severe respiratory diseases, such as acute respiratory distress syndrome (ARDS) or patients in need of surgery. These conditions require the use of ventilators and other advanced respiratory devices.

Hospitals and clinics have a team of healthcare professionals, including pulmonologists, respiratory therapists, and critical care nurses, who are trained to operate and manage respiratory care devices. This expertise ensures proper usage and patient care. Hospitals and clinics require a broad range of respiratory care devices to meet the diverse needs of patients. This includes devices for asthma management, sleep apnea treatment, oxygen therapy, and mechanical ventilation, among others.

Download Free Sample Report

Regional Insights

The North India region dominated the India Respiratory Care Devices Market in 2024. Higher population density can lead to a higher prevalence of respiratory diseases due to factors like air pollution, dust, and crowded living conditions. This increased disease burden drives the demand for respiratory care devices. West India, has a relatively better-developed healthcare infrastructure compared to some other regions. Well-established hospitals, clinics, and healthcare facilities are more likely to have advanced respiratory care equipment, leading to higher usage and market presence. The region is home to some of India's top government and private hospitals and medical institutions. These institutions often have access to greater resources and investments in medical equipment, including respiratory care devices. The region is home to several medical colleges and research institutions. This concentration of healthcare education and research can lead to greater awareness and utilization of advanced medical technologies, including respiratory care devices.

Recent Developments

• In January 2025, ResMed India launched the AirSense 11 CPAP system in the Indian market, featuring myAir and AirView digital platforms to enhance patient engagement, remote monitoring, and connected care access for individuals with sleep apnea.
• In March 2025, ResMed India’s AirSense 11 devices became commercially available, listed as “in stock” on the ResMed India online store, marking the active rollout of the company’s next-generation PAP therapy solutions in the country.
• In June 2025, NEIGRIHMS Shillong issued a Government e-Marketplace (GeM) bid for ICU ventilators (V2) with specifications covering adult, pediatric, and neonatal use, as well as advanced ventilatory parameters, signaling state-level tertiary care upgrades in respiratory support infrastructure.
• In July 2025, AIIMS Bhopal released a tender for rechargeable ventilator batteries under the Proprietary Article Certificate (PAC) category, indicating continued maintenance and lifecycle management investments for existing ventilator fleets.
• In 2025, the Bureau of Indian Standards (BIS) and central government notifications expanded the scope of Quality Control Orders (QCOs) and medical device standards, reinforcing compliance requirements for respiratory care equipment in both public procurement and market authorization contexts.
• In September 2024, Allied Medical showcased its Meditec AV(PC) portable ICU ventilator, featuring neonatal-to-adult coverage and comprehensive mode support, underscoring the sustained availability of indigenous ventilator solutions within India’s supplier ecosystem.
• In February 2024, Noccarc secured USD 2 million in funding from Indian Angel Network (IAN) and other investors to accelerate its respiratory device portfolio, including smart ventilators and connected ICU systems, supporting the company’s Make-in-India manufacturing and export readiness goals.
• In February 2024, Getinge, a leading global medical technology company, has introduced the state-of-the-art Servo-c mechanical ventilator to enhance respiratory care in India. This innovative device represents a significant advancement in meeting the diverse respiratory needs of both pediatric and adult patients nationwide. The Servo-c ventilator is designed with precision to provide lung-protective therapeutic tools, addressing the evolving demands of the healthcare sector. Getinge is committed to making advanced healthcare solutions accessible and affordable, ensuring hospitals across India can benefit from high-quality respiratory care technology.

Key Market Players

• India Medtronic Private Limited
• ResMed India Pvt. Ltd.
• Koninklijke Philips N.V.
• Masimo Corp
• Getinge Medical India Pvt. Ltd.
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare India Pvt Ltd
• Wipro GE Healthcare Pvt Ltd
• Hill-Rom India Private, Ltd.
• Becton, Dickinson and Company
• Opto Circuits India Ltd.
• Omron Healthcare India Pvt. Ltd.
• Nihon Kohden

Report Scope:

In this report, the India Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Respiratory Care Devices Market, By Product Type:

o   Therapeutic Devices

o   Monitoring Devices

o   Diagnostic Devices

o   Consumables & Accessories

• India Respiratory Care Devices Market, By Indication:

o   Chronic Obstructive Pulmonary Disease

o   Infectious Diseases

o   Asthma

o   Sleep Apnea

o   Others

• India Respiratory Care Devices Market, By End-User:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Others

• India Respiratory Care Devices Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Respiratory Care Devices Market.

Available Customizations:

India Respiratory Care Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Respiratory Care Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]